COMP <GO>
OMCL vs NVDA // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Omnicell Inc. ($0.001 par value) (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: OMCL 3
— NVDA 9
■ METRIC PARITY
LAST: $36.88 (+2.59%) • MKT CAP: $1.68B
options-implied-move
—
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
options-implied-move
9.01%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OMCL VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OMCL | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.50% | 74.67% | -32.17 | NVDA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.40% | 65.06% | -64.66 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.6x | 23.2x | +14.39 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 5.16% | 2.58% | +2.58 | OMCL | /fcf-yield <GO> |
| Operating Margin | 0.40% | 65.21% | -64.81 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 0.20% | 63.66% | -63.46 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 6.50% | 83.38% | -76.88 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.36 | 19.52 | -17.16 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | OMCL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 51.1 | +5.70 | OMCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 14.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.68B | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OMCL REV | NVDA REV | OMCL GROSS % | NVDA GROSS % | OMCL FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $1.18B | $130.50B | 42.5% | 75.0% | $86.9M | $60.85B |
| FY 2024 | $1.11B | $60.92B | 42.3% | 72.7% | $151.3M | $27.02B |
| FY 2023 | $1.15B | $26.97B | — | 56.9% | $181.1M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OMCL // BETA —
NVDA // BETA 2.04